Clinical Trials Browser

Phase 2/3 × Brain Neoplasms × Temozolomide × Clear all

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence